RBM39 and breast carcinoma: Mercier et al. found that RBM39 expression was positively correlated with tumor size in vitro and in vivo, and virus-mediated knockdown of RBM39 in ER-positive MCF-7 cells could significantly hinder the proliferation of human breast cancer cells and tumor growth in vivo [6].